ストックスクリーナーアプリを入手
1.23
6.03%
0.07
アフターアワーズ：
1.09
-0.14
-11.38%
前日終値:
$1.16
開ける：
$1.56
24時間の取引高:
63.59M
Relative Volume:
9.93
時価総額：
$833.42K
収益：
$1.22M
当期純損益:
$-3.26M
株価収益率:
-0.2001
EPS:
-6.1455
ネットキャッシュフロー:
$-6.38M
1週間 パフォーマンス:
+0.82%
1か月 パフォーマンス:
-25.90%
6か月 パフォーマンス:
-79.22%
1年 パフォーマンス:
-90.96%
1日の値動き範囲:
$1.1401
$1.76
1週間の範囲:
$1.06
$1.76
52週間の値動き範囲:
$1.06
$15.65
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile
名前
Scinai Immunotherapeutics Ltd Adr
セクター
電話
972-8-9302529
住所
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Compare SCNI vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SCNI
Scinai Immunotherapeutics Ltd Adr
|
1.23 | 833.42K | 1.22M | -3.26M | -6.38M | -6.1455 |
VRTX
Vertex Pharmaceuticals Inc
|
485.22 | 122.98B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
216.25 | 86.33B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
753.12 | 77.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
802.64 | 50.47B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.44 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Scinai Immunotherapeutics Ltd Adr (SCNI) 最新ニュース
Scinai files prospectus for resale of 2.7 million ADSs - scanx.trade
Scinai Immunotherapeutics regains Nasdaq compli... - Pluang
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
Nasdaq closes Scinai's $1 stock-price matter after 19 business days - Stock Titan
Scinai Immunotherapeutics (SCNI) Edges Higher to $1.71 as Biotech Micro-Cap Holds Key SupportWave Extension - dars.gov.et
Scinai Immunotherapeutics refocuses capital on NanoAb platform and CDMO business - TipRanks
Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business - Barchart.com
Scinai (NASDAQ: SCNI) updates $15M equity deal that could dilute investors - Stock Titan
Earnings call transcript: Scinai posts H1 2026 revenue growth as losses persist - Investing.com Nigeria
Earnings call transcript: Scinai posts H1 2026 revenue growth as losses persist - Investing.com
Scinai reports H1 2026 results, announces U.S. customer expansion - Investing.com India
Scinai Immunotherapeutics (NASDAQ: SCNI): Why Is A recent reverse share split that reset the chart structure in Focus Now? - Kalkine Media
Scinai (SCNI) Technicals: Ends Down by 5.59% at $3.04 in the Current Update; Levels: $2.89 and $3.19 Define the Nearby Reference Levels in the Latest ReadingFactor Valuation - careplusvn.com
Scinai (SCNI) Technicals: Ends Down by 5.59% at $3.04 in the Current Update; Levels: $2.89 and $3.19 Define the Nearby Reference Levels in the Latest ReadingTriangle Correction - dars.gov.et
Scinai reports H1 2026 results, announces U.S. customer expansion - Investing.com
Scinai (SCNI) Technicals: Ends Down by 5.59% at $3.04 in the Current Update; Levels: $2.89 and $3.19 Define the Nearby Reference Levels in the Latest ReadingOversold Bounce Ideas - dars.gov.et
Scinai (SCNI) Earnings Update: EPS Beats Its Estimate in the Latest Session; Price Move - dars.gov.et
What Could Scinai Immunotherapeutics (NASDAQ:SCNI) Reveal Today About Its Next Operating Milestones? - Kalkine Media
Scinai Immunotherapeutics Sets 1-for-10 ADS Ratio Change to Support Nasdaq Compliance - The Globe and Mail
Scinai Immunotherapeutics Sets 1-for-10 ADS Ratio Change to Support Nasdaq Compliance - TipRanks
Scinai (NASDAQ: SCNI) turns to reverse split to chase Nasdaq $1 minimum - Stock Titan
Scinai (SCNI) Latest Results Brief: EPS Exceeds Its Estimate at the Close; Post-Earnings Trading: Shares Finish 2.44% Up on the DayDividend Increase Stocks - dars.gov.et
Scinai (SCNI) Latest Results Brief: EPS Exceeds Its Estimate at the Close; Post-Earnings Trading: Shares Finish 2.44% Up on the DayEarnings Miss Streak - dars.gov.et
Scinai (SCNI) Latest Results Brief: EPS Exceeds Its Estimate at the Close; Post-Earnings Trading: Shares Finish 2.44% Up on the DayAnalyst Coverage Count - dars.gov.et
Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration - Barchart.com
Scinai Immunotherapeutics (SCNI) Slips 6.6% as Shares Test Key Support at $0.25Volatility Stop - careplusvn.com
Scinai Immunotherapeutics (SCNI) Slips 2.41% as Stock Hovers Near Key Support at $0.24Wedge Breakout - dars.gov.et
Scinai Immunotherapeutics (SCNI) Edges Higher Amid Tight Trading RangeCharm Flow - careplusvn.com
Scinai Immunotherapeutics (SCNI) Edges Higher Amid Tight Trading RangeGap Fill Strategy - dars.gov.et
Scinai Immunotherapeutics Ltd. (SCNI) Edges Higher in Tight Range as Support and Resistance Levels HardenRisk Reward Setups - careplusvn.com
Scinai Immunotherapeutics Q4 2023 Earnings: EPS Surprises to the Upside Despite No Revenue; Stock DeclinesShare Dilution Risk - careplusvn.com
Scinai Immunotherapeutics Q4 2023 Earnings: EPS Surprises to the Upside Despite No Revenue; Stock Declines - dars.gov.et
Scinai Immunotherapeutics Q4 2023 Earnings: EPS Surprises to the Upside Despite No Revenue; Stock DeclinesLow Growth Earnings - dars.gov.et
SCNIScinai Immunotherapeutics Ltd ADR Latest SEC Filings - Finviz
SCNIScinai Immunotherapeutics Ltd ADR Options - Finviz
Scinai Immunotherapeutics Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:SCNI) - TradingView
Price to sales forward of Scinai Immunotherapeutics Ltd. Sponsored ADR – MUN:2F5 - TradingView
Enterprise value to revenue forward of Scinai Immunotherapeutics Ltd. Sponsored ADR – MUN:2F5 - TradingView
Enterprise value to EBITDA forward of Scinai Immunotherapeutics Ltd. Sponsored ADR – MUN:2F5 - TradingView
Enterprise value to EBIT forward of Scinai Immunotherapeutics Ltd. Sponsored ADR – MUN:2F5 - TradingView
Why Scinai Immunotherapeutics stock is skyrocketing 90% higher today - MSN
Why Scinai Immunotherapeutics stock is skyrocketing 90% higher today - MSN
Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives - Barchart.com
Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives - Sahm
SCNI - Finviz
SCNI Technical Analysis | Trend, Signals & Chart Patterns | SCINAI IMMUNOTHERAPEUTICS LT (NASDAQ:SCNI) - ChartMill
Scinai appoints Eilon Elmalem as Yavne CDMO facility head - Investing.com
Scinai appoints Eilon Elmalem as Yavne CDMO facility head By Investing.com - Investing.com India
Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility - Barchart.com
Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe - Sahm
Scinai Immunotherapeutics Ltd Adr (SCNI) 財務データ
収益
当期純利益
現金流量
EPS
4.80%
大文字化:
|
ボリューム (24 時間):